MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

melatonin

  • Home
  • melatonin
Melatonin’s Impact on Glucose Metabolism: Risk Amplified by MTNR1B Diabetes Variant
Posted inDiabetes & Endocrinology news

Melatonin’s Impact on Glucose Metabolism: Risk Amplified by MTNR1B Diabetes Variant

Posted by By MedXY 08/03/2026
Melatonin impairs glucose tolerance and early insulin secretion, particularly in carriers of the MTNR1B diabetes risk allele, revealing critical mechanisms linking melatonin signaling to diabetes susceptibility and highlighting the need for genotype-based personalized care.
Read More
Melatonin Does Not Prevent Delirium in the Intensive Care Unit: Insights from a Comprehensive Meta-Analysis
Posted inCritical Care Internal Medicine news

Melatonin Does Not Prevent Delirium in the Intensive Care Unit: Insights from a Comprehensive Meta-Analysis

Posted by By MedXY 12/28/2025
A recent systematic review and meta-analysis of 13 randomized controlled trials concludes that melatonin fails to reduce the incidence of delirium or mortality in critically ill patients, challenging the routine use of this supplement in the intensive care setting.
Read More
Melatonin in the ICU Does Not Translate to Reduced Delirium Incidence
Posted inCritical Care Internal Medicine news

Melatonin in the ICU Does Not Translate to Reduced Delirium Incidence

Posted by By MedXY 12/28/2025
The DEMEL trial found that while 0.3 mg of melatonin achieved a superior pharmacokinetic profile over 3 mg, it failed to reduce delirium incidence or improve clinical outcomes in mechanically ventilated patients compared to placebo.
Read More
Unlocking Better Sleep: How Daily Walnut Consumption Enhances Melatonin Metabolism and Sleep Quality in Young Adults
Posted inFamily Medicine & Nutrition Neurology news Specialties

Unlocking Better Sleep: How Daily Walnut Consumption Enhances Melatonin Metabolism and Sleep Quality in Young Adults

Posted by By MedXY 09/16/2025
A randomized crossover trial shows that daily intake of 40 g walnuts increases urinary 6-sulfatoxymelatonin, reduces sleep latency, and improves global sleep quality in young adults, highlighting walnuts' potential as a natural sleep aid.
Read More
Midazolam Outperforms Melatonin as Premedication for Anxiety in Children Undergoing Elective Surgery: Insights from the MAGIC Trial
Posted innews Pediatrics Psychiatry Specialties

Midazolam Outperforms Melatonin as Premedication for Anxiety in Children Undergoing Elective Surgery: Insights from the MAGIC Trial

Posted by By MedXY 09/07/2025
The MAGIC trial reveals midazolam’s superior efficacy over melatonin in reducing preoperative anxiety in children undergoing general anaesthesia, despite melatonin’s favorable safety profile. Challenges in recruitment and implications for future research are discussed.
Read More
Unlocking Better Sleep: The Science and Safety of Popular Sleep Supplements
Posted inFamily Medicine & Nutrition Neurology news Specialties

Unlocking Better Sleep: The Science and Safety of Popular Sleep Supplements

Posted by By MedXY 08/18/2025
Explore scientifically supported sleep supplements like melatonin, jujube seed extract, GABA, reishi spore powder, valerian root, ashwagandha, and magnesium, their benefits, risks, and expert guidance for improving sleep quality.
Read More
  • Reversing Epigenetic Aging in Psoriasis: The Impact of Tildrakizumab over 52 Weeks
  • Janus Kinase Inhibitors: Transforming Treatment Paradigms in Lymphomas and Immune-Mediated Complications
  • Unveiling Metabolic Signatures: Glucose and Methionine PET Imaging in Disorders of Consciousness Post-Brain Injury
  • Bridging the Communication Gap in Shared Airway Management: Insights from a Multicenter Survey of Anesthesiologists
  • Teprotumumab Versus Intravenous Glucocorticoids in Thyroid Eye Disease: Insights from a Japanese MRI Study
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis prostate cancer public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top